Ajanta Pharma Dividendes et rachats
Dividende contrôle des critères 5/6
Ajanta Pharma est une société versant des dividendes avec un rendement actuel de 1.9% qui est bien couvert par les bénéfices. La prochaine date de paiement est le 27th November, 2024 avec une date ex-dividende de 6th November, 2024.
Informations clés
1.9%
Rendement du dividende
1.0%
Rendement des rachats
| Rendement total pour l'actionnaire | 2.9% |
| Rendement futur des dividendes | 1.0% |
| Croissance des dividendes | 9.6% |
| Prochaine date de paiement du dividende | 27 Nov 24 |
| Date ex-dividende | 06 Nov 24 |
| Dividende par action | ₹56.000 |
| Ratio de distribution | 78% |
Mises à jour récentes sur les dividendes et les rachats
Recent updates
Revenue Beat: Ajanta Pharma Limited Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Oct 31
Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Sep 10We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease
Aug 23Ajanta Pharma Limited Just Recorded A 11% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 04Some Confidence Is Lacking In Ajanta Pharma Limited's (NSE:AJANTPHARM) P/E
Aug 01With EPS Growth And More, Ajanta Pharma (NSE:AJANTPHARM) Makes An Interesting Case
Jun 01Ajanta Pharma Limited (NSE:AJANTPHARM) Analysts Are Pretty Bullish On The Stock After Recent Results
May 05Ajanta Pharma Limited's (NSE:AJANTPHARM) Intrinsic Value Is Potentially 23% Below Its Share Price
Apr 05We Think Ajanta Pharma (NSE:AJANTPHARM) Can Manage Its Debt With Ease
Feb 23Ajanta Pharma Limited (NSE:AJANTPHARM) Investors Are Less Pessimistic Than Expected
Dec 23Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Aug 26These 4 Measures Indicate That Ajanta Pharma (NSE:AJANTPHARM) Is Using Debt Reasonably Well
Feb 07Here's Why Ajanta Pharma (NSE:AJANTPHARM) Has Caught The Eye Of Investors
Oct 24Estimating The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Aug 25Is Now The Time To Put Ajanta Pharma (NSE:AJANTPHARM) On Your Watchlist?
Jul 19A Look At The Intrinsic Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Apr 28Ajanta Pharma (NSE:AJANTPHARM) Seems To Use Debt Quite Sensibly
Mar 14I Built A List Of Growing Companies And Ajanta Pharma (NSE:AJANTPHARM) Made The Cut
Feb 06Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Dec 13Ajanta Pharma (NSE:AJANTPHARM) Will Pay A Dividend Of ₹9.50
Oct 31Here's Why We Think Ajanta Pharma (NSE:AJANTPHARM) Is Well Worth Watching
Sep 22Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 27% Discount?
Sep 08Does Ajanta Pharma (NSE:AJANTPHARM) Have A Healthy Balance Sheet?
Aug 26Here's Why Shareholders Will Not Be Complaining About Ajanta Pharma Limited's (NSE:AJANTPHARM) CEO Pay Packet
Jul 07Should You Be Adding Ajanta Pharma (NSE:AJANTPHARM) To Your Watchlist Today?
Jun 14Is Ajanta Pharma Limited (NSE:AJANTPHARM) Trading At A 30% Discount?
May 15Ajanta Pharma Limited (NSE:AJANTPHARM) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 10Ajanta Pharma Limited's (NSE:AJANTPHARM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Mar 11Does Ajanta Pharma (NSE:AJANTPHARM) Deserve A Spot On Your Watchlist?
Feb 24The Ajanta Pharma (NSE:AJANTPHARM) Share Price Is Up 56% And Shareholders Are Holding On
Jan 30
What Can We Make Of Ajanta Pharma's (NSE:AJANTPHARM) CEO Compensation?
Jan 18Estimating The Fair Value Of Ajanta Pharma Limited (NSE:AJANTPHARM)
Jan 06Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: Les paiements de dividendes de AJANTPHARM ont été volatils au cours des 10 dernières années.
Dividende croissant: Les paiements de dividendes de AJANTPHARM ont augmenté au cours des 10 dernières années.
Rendement des dividendes par rapport au marché
| Ajanta Pharma Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (AJANTPHARM) | 1.9% |
| 25% du marché (IN) | 0.3% |
| 25% du marché (IN) | 1.2% |
| Moyenne du secteur (Pharmaceuticals) | 0.7% |
| Analyste prévisionnel (AJANTPHARM) (jusqu'à 3 ans) | 1.0% |
Dividende notable: Le dividende de AJANTPHARM ( 1.9% ) est supérieur à celui des 25 % des payeurs de dividendes les plus faibles du marché Indian ( 0.25% ).
Dividende élevé: Le dividende de AJANTPHARM ( 1.9% ) se situe dans les 25 % des premiers payeurs de dividendes du marché Indian ( 1.17% )
Bénéfice distribué aux actionnaires
Couverture des revenus: À son ratio de distribution actuel (77.5%), les paiements de AJANTPHARM sont couverts par les bénéfices.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: Avec son taux de distribution en espèces actuel ( 76.6% ), les paiements de dividendes de AJANTPHARM sont couverts par les flux de trésorerie.